Amedisys, Inc.
Amedisys, Inc.（AMED）内幕交易
基于 SEC Form 4 的买入/卖出笔数、买卖比与情绪标签；可在本季度与近12个月之间切换；下方为季度图与交易明细。
SEC EDGAR · FMP · AMED · 截至 2026年6月8日
活动摘要
买入笔数
0
P-Purchase only
卖出笔数
2
近12个月
买卖比
0.00
Buy/Sell (by trades)
整体情绪
Amedisys, Inc.内部人在过去近12个月主要在卖出股份，卖出行为通常由预设的Rule 10b5-1计划驱动，不一定代表对公司的负面看法。
▸ 数据来源：SEC EDGAR · Form 3 & 4 · 买入仅计P-Purchase · 卖出仅计S-Sale
截至 2026年6月8日
AMED 季度内部人买卖趋势
AMED 内幕交易卖出 · AMED 内幕交易买入 · 季度活动
Mobile shows last 4Q · Desktop shows full 8Q
▸ 数据来源：SEC EDGAR · Form 3 & 4 · 最近8季度
As of Jun 8, 2026
活跃内部人
近12个月交易最活跃 · AMED CEO内幕交易
显示全部内部人 · 点击卡片过滤下方交易表
▸ 按reportingName聚合 · 近12月交易次数Top5 · 无额外API
近期内幕交易记录
AMED 高管卖出股份 · AMED 董事内幕交易 · SEC Form 4申报
横向滑动查看全部列
| 日期 | 内部人 | 类型 | 股数 | 总金额 | 申报 |
|---|---|---|---|---|---|
| Aug 14, 2025 | Coye Molly Joel Director | Other | 8,818 | $9 | Form 4 |
| Aug 14, 2025 | Klapstein Julie D Director | Other | 16,031 | $16 | Form 4 |
| Aug 14, 2025 | Kusserow Paul B. K. Director | Other | 621 | — | Form 4 |
| Aug 14, 2025 | Kusserow Paul B. K. Director | Other | 439,124 | $439 | Form 4 |
| Aug 14, 2025 | Rideout Jeffrey A Director | Other | 9,335 | $9 | Form 4 |
| Aug 14, 2025 | Muscato Nick Chief Strategy Officer | Other | 3,067 | $3 | Form 4 |
| Aug 14, 2025 | Muscato Nick Chief Strategy Officer | Option | 3,468 | — | Form 4 |
| Aug 14, 2025 | Muscato Nick Chief Strategy Officer | Other | 212 | — | Form 4 |
| Aug 14, 2025 | Kline Teresa L. Director | Other | 9,818 | $10 | Form 4 |
| Aug 14, 2025 | CAPPS VICKIE L Director | Other | 9,818 | $10 | Form 4 |
| Aug 14, 2025 | Griffin Jennifer G Chief Legal Officer | Other | 10,700 | $11 | Form 4 |
| Aug 14, 2025 | Griffin Jennifer G Chief Legal Officer | Other | 341 | — | Form 4 |
| Aug 14, 2025 | Ginn Scott G EVP, CFO & COO | Other | 31,211 | $31 | Form 4 |
| Aug 14, 2025 | Ginn Scott G EVP, CFO & COO | Option | 10,399 | — | Form 4 |
| Aug 14, 2025 | Ginn Scott G EVP, CFO & COO | Other | 2,714 | — | Form 4 |
| Aug 14, 2025 | Bohnert Denise M. Chief Compliance Officer | Other | 9,283 | $9 | Form 4 |
| Aug 14, 2025 | Bohnert Denise M. Chief Compliance Officer | Option | 3,468 | — | Form 4 |
| Aug 14, 2025 | Bohnert Denise M. Chief Compliance Officer | Other | 214 | — | Form 4 |
| Aug 14, 2025 | Guidroz Allyson CAO | Other | 898 | $1 | Form 4 |
| Aug 14, 2025 | Guidroz Allyson CAO | Other | 1.5 | — | Form 4 |
| Aug 14, 2025 | Ashworth Richard M President and CEO · Director | Other | 45,870 | $46 | Form 4 |
| Aug 14, 2025 | Ashworth Richard M President and CEO · Director | Option | 62,641 | — | Form 4 |
| Aug 14, 2025 | Ashworth Richard M President and CEO · Director | Option | 39,850 | — | Form 4 |
| Aug 14, 2025 | Ashworth Richard M President and CEO · Director | Other | 39,850 | — | Form 4 |
| Aug 14, 2025 | Samuels Ivanetta Davis Director | Other | 7,600 | $8 | Form 4 |
Ashworth Richard M
President and CEO · Director
日期
Aug 14
股数
45,870
均价
$0.00
总金额
$46
⚡ = 金额≥$100万 · Award/Option价格显示— · 仅Form4 · 仅普通股
▸ 数据来源：SEC EDGAR · Form 4 申报 · ⚡ = 金额≥$100万 · Award/Option 价格显示 —
关于 AMED 内幕交易
AMED 内幕交易
Amedisys, Inc.（AMED）内幕交易数据来源于公司内部人（包括Guidroz Allyson (CAO), Muscato Nick (Chief Strategy Officer), Ginn Scott G (EVP, CFO & COO)）提交的SEC Form 4申报文件。过去12个月内，5位内部人向SEC提交了交易申报。AMED内部人近期主要在卖出，这可能反映预设的10b5-1计划执行，而非方向性判断。
如需查看Amedisys, Inc.机构持仓比例和内部人持股百分比，请访问持仓（Ownership）标签页 → Ownership tab →
常见问题
AMED 内幕交易 · 5个问题Amedisys, Inc.（AMED）的内部人包括高管和董事，如Guidroz Allyson (CAO), Muscato Nick (Chief Strategy Officer), Ginn Scott G (EVP, CFO & COO)等。过去12个月内，5位内部人向SEC提交了Form 4交易申报。内部人须在交易日期后2个工作日内完成申报。
▸ 数据来源：FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · RSU归属不计入情绪 · As of Jun 8, 2026